🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Status
Terminated
Location
University of Connecticut Health Center
Start Date
2017-07-18
Trial ID
NCT03234465
The objective of the present trial is: * to determine the dose limiting to...
Status
Withdrawn
Location
Gustave Roussy Institute,
Start Date
2012-06
Trial ID
NCT01764009
Treatments Being Tested
The Brigham and Women's Hospital (BWH) Patient Safety Learning Laboratory (...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2015-04
Trial ID
NCT02969343
Treatments Being Tested
This phase I trial studies the side effects and best dose of stereotactic b...
Status
Completed
Location
University of Wisconsin Carbone Cancer Center
Start Date
2014-04-08
Trial ID
NCT01918644
This phase I trial studies the side effects and best way to give metformin ...
Status
Withdrawn
Location
Fox Chase Cancer Center
Start Date
TBD
Trial ID
NCT02050009
Treatments Being Tested
Phase 2b clinical trial to evaluate the safety and efficacy of intranasal a...
Status
Completed
Location
Gorgas Memorial Research Hospital
Start Date
2021-01-21
Trial ID
NCT04951349
Treatments Being Tested
This study seeks to understand the performance of MRI to characterize pancr...
Status
Enrolling By Invitation
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-18
Trial ID
NCT05659147
This is a randomized, double-blind, placebo-parallel intervention clinical ...
Status
Unknown
Location
The Second Affiliated Hospital of Chongqing Medical University
Start Date
2022-05-01
Trial ID
NCT06127498
This pilot clinical trial studies the side effects and best dose of ruxolit...
Status
Completed
Location
City of Hope Medical Center
Start Date
2016-11-13
Trial ID
NCT02917096
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condit...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2020-06-02
Trial ID
NCT03985423
Treatments Being Tested